PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-08-03

Date Title Company
03-Aug-2020 Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China Innovent Biologics, Inc.
03-Aug-2020 VistaGen Therapeutics Announces Pricing of $12.5 Million Underwritten Public Offering of Common Stock VistaGen Therapeutics